Skip to main content

UBS Group AG

Position in TNGX — Tango Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in TNGX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,994,272
-$2,636,171 QoQ
Shares Held
383,694
-45.1% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 247 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in TNGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. TNGX ranks #105 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TNGX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,994,272 383,694
2026-03-31 $14,630,443 699,352
2025-12-31 $8,775,456 990,458
2025-09-30 $1,348,015 160,478
2025-06-30 $1,418,762 277,102
2025-03-31 $210,068 153,335
2024-12-31 $1,280,721 414,473
2024-09-30 $3,394,398 440,831
2024-06-30 $1,298,282 151,315
2024-03-31 $1,256,314 158,226
2023-09-30 $348,924 30,988
2023-06-30 $103,368 31,135
2023-03-31 $80,943 20,492
2022-12-31 $119,342 16,461
2022-06-30 $87,089 19,225
2022-03-31 $15,539 2,050
2021-12-31 $28,268 2,584
2021-06-30 BCTG 3,259
2021-03-31 BCTG 2,799
2020-12-31 BCTG 1,148
2020-09-30 BCTG 1,298